OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
M. Gallorini, Simone Carradori, Emiliano Panieri, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 636-662
Closed Access | Times Cited: 14

Showing 14 citing articles:

Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases
Sehyun Oh, Xuan Linh, Jiwoo Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1066-1079
Open Access | Times Cited: 12

Nephroprotective Potential of Rhamnazin Against Cadmium-Induced Kidney Damages via Activation of Nrf2/Keap1 Pathway
M. Fozia Anjum, Nazia Ehsan, Arfa Tahir, et al.
Natural Product Communications (2025) Vol. 20, Iss. 1
Open Access

Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation
Jeong‐Hoon Jang, Do-Hee Kim, Kyung‐Soo Chun
Archives of Pharmacal Research (2025)
Closed Access

2-Substituted-4,7-dihydro-4-ethylpyrazolo[1,5-a]pyrimidin-7-ones alleviate LPS-induced inflammation by modulating cell metabolism via CD73 upon macrophage polarization
Alessia Ricci, Susi Zara, Fabrizio Carta, et al.
Molecular Immunology (2024) Vol. 170, pp. 99-109
Closed Access | Times Cited: 3

Natural products as a source of new anticancer chemotypes
Francesco Melfi, Simone Carradori, Noemi Mencarelli, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 721-744
Closed Access | Times Cited: 9

The Molecular Characterization and Antioxidant Defense of a Novel Nrf2 from the Pacific Abalone Haliotis discus hannai Ino
Kun Qiao, Qianhui Huang, Bei Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12429-12429
Open Access | Times Cited: 1

NRF2: New Mechanistic Insights and Therapeutic Perspectives
Jerzy W. Kupiec‐Weglinski
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 632-635
Closed Access | Times Cited: 4

Diabetic neuropathy: A NRF2 disease?
Monica Neagu, Carolina Constantin, Mihaela Surcel, et al.
Journal of Diabetes (2023) Vol. 16, Iss. 9
Open Access | Times Cited: 4

Iron chelators as mitophagy agents: Potential and limitations
Tereza Brogyányi, Zdeněk Kejík, Kamila Veselá, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117407-117407
Open Access

Activation of Nuclear Factor Erythroid 2-Related Factor-2 by Oxylipin from Mangifera indica Leaves
Atif Ali Khan Khalil, Min Seok Woo, Dong‐Min Kang, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1119-1119
Open Access

Scope of Theoretical Approaches Studying the Ligand-Nrf2 Interactions
Marvin A. Soriano‐Ursúa, Ana L. Ocampo-Néstor, Melvin N. Rosalez, et al.
IntechOpen eBooks (2024)
Open Access

NRF-Mediated Autophagy and UPR: Exploring New Avenues to Overcome Cancer Chemo-Resistance
Sanaz Dastghaib, Sayed Mohammad Shafiee, Fatemeh Ramezani, et al.
European Journal of Pharmacology (2024), pp. 177210-177210
Open Access

Page 1

Scroll to top